If you have been reading about research chemical and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Though BMI is often used to help assess for excess weight, it is not a perfect representation of a person's body fat percentage. For example, an individual can have a higher than normal BMI but a normal body fat percentage if they have higher than average muscle mass. This is because excess muscle contributes to a higher weight. Since BMI is not a perfect representation of a person's body fat percentage, other measurements like waist circumference are often used to better assess for unhealthy excess weight. The following table shows how different ranges of BMIs are often categorized into underweight, normal weight, overweight, and obese:
Long before the born secret issues associated with the restricted data provisions of the US Atomic Energy Act of 1946, the US Invention Secrecy Act of 1951, and the US Patent and Trademark Law Amendments Act of 1980 and/or the increasing concerns with respect to the on-going biopiracy of natural products, and in the early 20th-century atmosphere of cultural change — not only in the proliferation of vocational universities, rather than research universities, but also in the gradual move from the disciplinary concentration on "pure science" and, perhaps, aspects of "applied science", to that of fostering "industrial science" in both primary and secondary industries — the ethical question of whether or not those universities devoted to "pure science" (viz., the discovery/creation, distillation, refinement, diffusion, and the free dissemination of knowledge for the benefit of the public) should have any interest in "applied science", and further, whether they should have any commercial interest in the products of their research and, in particular, whether they should seek patents for their discoveries. In his 1926 Presidential address to the Society of American Bacteriologists (HZ.1), Hans Zinsser spoke against "the growing tendency on the part of medical scientific workers, and bacteriologists especially, to patent discoveries of practical therapeutic and public health value" (p.157).
=== tim-tin === Tim-AK Timecelles timefurone (INN) timegadine (INN) timelotem (INN) Timentin timepidium bromide (INN) timiperone (INN) timirdine (INN) timobesone (INN) timofibrate (INN) Timolide timolol (INN) timonacic (INN) timoprazole (INN) Timoptic tinabinol (INN) Tinactin Antifungal Tinaderm Tinamed tinazoline (INN) TinBen Tindal Tindamax Ting tinidazole (INN) tinisulpride (INN) tinofedrine (INN) tinoridine (INN) Tinver tinzaparin sodium (INN)
Relative to SARMs, supraphysiological doses of testosterone (300–600 mg/week intramuscular testosterone enanthate) over similar timeframes, like 20 weeks, have been found to result in lean body mass gains of 5 to 8 kg in healthy young men. In addition to selectivity for muscle and bone over the prostate gland, LGD-4033 has also been stated by Ligand Pharmaceuticals researchers to have reduced strength in the sebaceous glands. Reduced activity in stimulating sebaceous gland formation, to about 30 to 50% of that produced by DHT at doses with similar anabolic potency in rats, has also been reported for certain other SARMs, like the steroidal agents TFM-4AS-1 and MK-0773. In addition, enobosarm and MK-0773 have been reported to limitedly stimulate the sebaceous glands in small short-term clinical studies in women.
Sources: en.wikipedia.org
== Pre-clinical models == Muscle-atrophy can be induced in pre-clinical models (e.g. mice) to study the effects of therapeutic interventions against muscle-atrophy. Restriction of the diet, i.e. caloric restriction, leads to a significant loss of muscle mass within two weeks, and loss of muscle-mass can be rescued by a nutritional intervention. Immobilization of one of the hindlegs of mice leads to muscle-atrophy as well, and is hallmarked by loss of both muscle mass and strength. Food restriction and immobilization may be used in mouse models and have been shown to overlap with mechanisms associated to sarcopenia in humans.
1993/2629) Shropshire's Community Health Service National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2630) Hill Livestock (Compensatory Allowances) Regulations 1993 (S.I. 1993/2631) National Lottery etc. Act 1993 (Commencement No. 1 and Transitional Provisions) Order 1993 (S.I. 1993/2632) South East London Mental Health National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2633) Haringey Health Care National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2634) North Staffordshire Combined Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2635) Lincoln District Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2636) Swindon and Marlborough National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2637) Louth and District Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2638) North Kent Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2639) Medway National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2640) Queen Victoria Hospital National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2641) Dartford and Gravesham National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2642) Worthing and Southlands Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2643) Gipsy Encampments (Borough of Holderness) Order 1993 (S.I. 1993/2644) Norfolk Mental Health Care National Health Service Trust (Establishment) Order 1993 (S.I.
== Use == In agriculture and horticulture, lime sulfur is sold as a spray to control fungi, bacteria, and insects. On deciduous trees, it can be sprayed during the winter on the surface of the bark in high concentrations, but because lime sulfur can burn foliage, it must be heavily diluted before being sprayed onto herbaceous crops, especially during warm weather. Lime sulfur is approved for use on organic crops in the European Union and the United Kingdom. Bonsai enthusiasts use undiluted lime sulfur to bleach, sterilize, and preserve deadwood on bonsai trees while giving it an aged look. Rather than being sprayed over the entire tree, as in pesticidal use, lime sulfur is painted directly onto the exposed deadwood and is often colored with a small amount of dark paint to make it look more natural. Without added pigments, the lime sulfur solution bleaches wood to a bone-white color that takes time to weather and become natural-looking. In the very specific case of bonsai culture, if lime sulfur is carefully applied by hand with a small brush and does not come into direct contact with the leaves or needles, this technique can also be used on evergreen bonsai trees as well as other types of green trees. However, this does not apply to normal use on common trees with green leaves. Diluted solutions of lime sulfur (between 1:16 and 1:32) are also used as a dip for pets to help control ringworm (a fungus), mange, and other dermatoses and parasites. Undiluted lime sulfur is corrosive to the skin and eyes and can cause serious injury, such as blindness.
== Uses == Coca leaves have been used by Andean civilizations since ancient times. In ancient Wari culture, Inca culture, and through modern successor indigenous cultures of the Andes Mountains, coca leaves are chewed, taken orally in the form of a tea, or alternatively, prepared in a sachet wrapped around alkaline burnt ashes, and held in the mouth against the inner cheek; it has traditionally been used as an anorectic and to combat the effects of cold and altitude sickness, although its actual effectiveness has never been systematically studied. Globally, in 2019, cocaine was used by an estimated 20 million people (0.4% of adults aged 15 to 64 years). The highest prevalence of cocaine use was in Australia and New Zealand (2.1%), followed by North America (2.1%), Western and Central Europe (1.4%), and South and Central America (1.0%). Since 1961, the Single Convention on Narcotic Drugs has required countries to make recreational use of cocaine a crime. In the United States, cocaine is regulated as a Schedule II drug under the Controlled Substances Act, meaning that it has a high potential for abuse but has an accepted medical use. While rarely used medically anymore, its accepted uses include serving as a topical local anesthetic for the upper respiratory tract and as an antihemorrhagic agent to stop bleeding in the mouth, throat, and nasal cavities.
== Properties == The physical and chemical properties of magnetic nanoparticles largely depend on the synthesis method and chemical structure. In most cases, the particles range from 1 to 100 nm in size and may display superparamagnetism.
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
Sealed, desiccated and protected from light, at -20 °C or lower for long-term storage. Short-term storage at refrigerator temperature is common in working laboratories.